- £391.86m
- £474.96m
- £335.10m
- 45
- 30
- 52
- 34
2019 May 31st | R2020 May 31st | 2021 May 31st | 2022 May 31st | 2023 May 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 251 | 264 | 271 | 315 | 335 |
Cost of Revenue | |||||
Gross Profit | 100 | 104 | 111 | 133 | 132 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 231 | 251 | 253 | 280 | 333 |
Operating Profit | 19.5 | 12.6 | 17.3 | 34.7 | 1.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 17.8 | 9.6 | 14.8 | 31 | -4.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 12.3 | 6.9 | 11.9 | 21.9 | -6 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 13.5 | 6.4 | 10 | 23 | -4.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 13.5 | 6.4 | 10 | 23 | -4.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.065 | 0.068 | 0.103 | 0.083 | 0.04 |
Dividends per Share |